Last year | Last five years | All
2026 Original Articles
- Silberbauer L, Eggerstorfer B, Michenthaler P, Reichel S, Stimpfl T, Vanicek T, Naderi-Heiden A, Kasper S, Lanzenberger R, Gryglewski G (2026) Oral ketamine for the treatment of major depressive and bipolar disorder, a randomized controlled trial and meta-analysis J Affect Disord, 394: 120466
| Weblink |
2025 Original Articles
- Müller T, Künzi A, Heitlinger E, Krämer B, von Känel R, Hättenschwiler J, Hilpert M, Imboden C, Holsboer-Trachsler E, Hatzinger M, Kasper S, Bandelow B, Seifritz E (2025) Comparative efficacy and acceptability of anxiolytic drugs for the treatment of anxiety disorders: a systematic review and network meta-analysis Eur Arch Psychiatry Clin Neurosci,
| Weblink | - Serretti A, Souery D, Kasper S, Zohar J, Montgomery S, Ferentinos P, Rujescu D, Ferri R, Fanelli G, Fabbri C, Zanardi R, Benedetti F, Baune B, Mendlewicz J (2025) Schizophrenia Genetics Modulates Clinical Depressive Features Am. J. Med. Genet. B Neuropsychiatr. Genet. ,
| Weblink | - Serretti A, Souery D, Kasper S, Bartova L, Zohar J, Montgomery S, Ferentinos P, Rujescu D, Ferri R, Fanelli G, Zanardi R, Benedetti F, Baune B, Mendlewicz J (2025) Polygenic liability to C-reactive protein defines immunometabolic depression phenotypes and influences antidepressant therapeutic outcomes Genomic Psychiatry , 1 (5): 30-35
| Weblink | - Kasper S (2025) Siegfried Kasper: The importance of back-translation of clinical findings to basic science Brain Medicine, 1 (5): 30-33
| Weblink | - Wegener G, Lerer B, Frazer A, Grace A, Ikeda K, Gobbi G, Young A, Zohar J, Blier P, Kasper S, Krystal J, Yamawaki S, Philips A, Möller H, Belmaker R, Atwoli L, Nutt D, Harvey B, Seedat S, Berk M, Emsley R (2025) In Memoriam: Professor Dan J. Stein (1962-2025) – A Global Pioneer with an African Heart Int. J. Neuropsychopharmacol.,
| Weblink | - Schlosser G, Murgaš M, Godbersen G, Reichel S, Silberbauer L, Nics L, Winkler D, Stimpfl T, Hacker M, Kasper S, Rujescu D, Lanzenberger R, Spies M (2025) Human in vivo assessment of ketamine binding of the serotonin transporter—follow up at a higher dose Front Neurosci, 19: 651016
| Weblink | - Abondio P, Fanelli G, Baldini V, Bacalini M, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Serretti A, Monteleone A, Grassi L, Atti A, Menchetti M, Fabbri C, De Ronchi D (2025) Polygenic predisposition to transdiagnostic symptom dimensions and treatment outcomes across psychiatric disorders Prog Neuropsychopharmacol Biol Psychiatry, 142: 111512
| Weblink | - Serretti A, Kasper S, Bartova L, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Kautzky A, Attanasio F, Zanardi R, Fabbri C, Baune B, Ferri R, Mendlewicz J (2025) Clinical predictors of treatment resistant depression Eur Neuropsychopharmacol, 98: 26-34
| Weblink | - White I, Luca A, Luca M, Bartova L, Kasper S, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Mendlewicz J, Zanardi R, Ferri R, Lanza G, Rodolico A, Signorelli M, Serretti A (2025) The impact of depression on functioning: Relation to medication response and other predictors Psychiat Res, 351: 116599
| Weblink | - Luca A, Luca M, Kasper S, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Mendlewicz J, Zanardi R, Ferri R, Lanuzza B, Pecorino B, Baune B, Fanelli G, Fabbri C, Serretti A (2025) Mild motor signs and depression: more than just medication side effects? Eur Arch Psychiatry Clin Neurosci,
| Weblink | - Kasper S, Incalzi R, Bozzali M, Morgado P, Siwek M (2025) Managing depression in the elderly: real-world clinical considerations and perspectives Int Clin Psychopharmacol, 40: 339-352
| Weblink | - Kautzky A, Bartova L, Dold M, Souery D, Montgomery S, Zohar J, Mendlewicz J, Fabbri C, Serretti A, Tretiakov E, Rujescu D, Harkany T, Kasper S (2025) Symptom networks in major depressive disorder and treatment response: special focus on TRD Eur Psychiatry, 68 (1): e61
| Weblink | - Murgaš M, Milz C, Stöhrmann P, Unterholzner J, Nics L, Kranz G, Hahn A, Hacker M, Kasper S, Lanzenberger R, Godbersen G (2025) In vivo serotonin 1A receptor distribution in treatment-resistant depression Transl Psychiat, 15
| Weblink | - Oliva V, Possidente C, Fanelli G, Domschke K, Minelli A, Gennarelli M, Martini P, Bortolomasi M, Squassina A, Pisanu C, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Baune B, Vieta E, Serretti A, Fabbri C (2025) Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis Eur Neuropsychopharmacol, 96: 17-27
| Weblink | - Pifl C, Wolf A, Elevado M, Scholze P (2025) α7‐Nicotinic Acetylcholine Receptor and Mutated α‐Synuclein Interact in Motor Behaviour and Nigrostriatal Dopamine—Findings With Potential Relevance for a Protective Effect of Cigarette Smoking and Parkinson's Disease Eur J Neurosci, 61 (6)
- Luca M, Luca A, Messina A, Bartova L, Kasper S, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Mendlewicz J, Zanardi R, Ferri R, Lanuzza B, Benedetti F, Pecorino B, Baune B, Fanelli G, Fabbri C, Serretti A (2025) Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex J Affect Disord, 375: 249-255
| Weblink | - Calabrò M, Fabbri C, Serretti A, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, Colombo C, Zanardi R, De Ronchi D, Crisafulli C (2025) A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors Psychiat Gen, 35 (2): 17-25
| Weblink | - Spies M, Kasper S, Frey R, Baldinger-Melich P (2025) KET or ECT for treatment-resistant depression? Int J Psychiatry Clin Pract,
| Weblink | - Kasper S, Incalzi RA, Bozzali M, Morgado P, Siwek M (2025) Managing Depression in the Elderly: Real-World Clinical Considerations and Perspectives on the Use of Trazodone. International Clinical Psychopharmacology Int Clin Psychopharmacol,
| Weblink | - Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Electronic address: andrew.mcintosh@ed.ac.uk; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium including Kasper S (2025) Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies Cell, 188: 640–652
| Weblink | - Olgiati P, Kasper S, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Zanardi R, Fugger G, Ferri R, Tripodi M, Baune B, Fabbri C, Mendlewicz J, Serretti A (2025) Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues J Affect Disord, 369: 1021-1030
| Weblink |
